A. Adlouni

895 total citations
31 papers, 716 citations indexed

About

A. Adlouni is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, A. Adlouni has authored 31 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nutrition and Dietetics. Recurrent topics in A. Adlouni's work include Cholesterol and Lipid Metabolism (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). A. Adlouni is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). A. Adlouni collaborates with scholars based in Morocco, France and Canada. A. Adlouni's co-authors include Noreddine Ghalim, A. Drissi, Abdellah Benslimane, Jean Lecerf, Mounia Cherki, Mariame El Messal, Houda Bennani, Jean Fiet, Abdelouahed Khalil and Rachid Saı̈le and has published in prestigious journals such as Clinica Chimica Acta, Atherosclerosis and Pharmacological Research.

In The Last Decade

A. Adlouni

30 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Adlouni Morocco 14 269 170 166 136 127 31 716
M.-I. Covas Spain 10 198 0.7× 230 1.4× 159 1.0× 110 0.8× 77 0.6× 14 882
José Manuel Santos‐Lozano Spain 17 414 1.5× 128 0.8× 242 1.5× 90 0.7× 130 1.0× 42 1.2k
Meera Penumetcha United States 16 144 0.5× 139 0.8× 179 1.1× 117 0.9× 59 0.5× 24 641
Ursel Wahrburg Germany 18 259 1.0× 135 0.8× 582 3.5× 209 1.5× 198 1.6× 27 1.1k
R.P. Mensink Netherlands 11 113 0.4× 161 0.9× 288 1.7× 138 1.0× 91 0.7× 23 663
Fernando Lopez‐Segura Spain 18 257 1.0× 164 1.0× 359 2.2× 366 2.7× 264 2.1× 26 1.1k
Marjorie Bell United States 16 202 0.8× 82 0.5× 387 2.3× 118 0.9× 167 1.3× 22 875
Christine Greene United States 7 129 0.5× 209 1.2× 105 0.6× 74 0.5× 116 0.9× 10 565
JT Judd United States 10 339 1.3× 156 0.9× 542 3.3× 201 1.5× 216 1.7× 11 1.2k
Rianne Leenen Netherlands 8 136 0.5× 395 2.3× 161 1.0× 139 1.0× 74 0.6× 8 819

Countries citing papers authored by A. Adlouni

Since Specialization
Citations

This map shows the geographic impact of A. Adlouni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Adlouni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Adlouni more than expected).

Fields of papers citing papers by A. Adlouni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Adlouni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Adlouni. The network helps show where A. Adlouni may publish in the future.

Co-authorship network of co-authors of A. Adlouni

This figure shows the co-authorship network connecting the top 25 collaborators of A. Adlouni. A scholar is included among the top collaborators of A. Adlouni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Adlouni. A. Adlouni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Habbal, Rachida, et al.. (2017). Argan oil improves dyslipidemia of metabolic syndrome: Human interventional study. 1(2). 56–63. 1 indexed citations
2.
Adlouni, A., et al.. (2013). Prevalence and risk factors of cognitive dysfunction in chronic hemodialysis patients. Aging & Mental Health. 18(2). 207–211. 20 indexed citations
3.
Messal, Mariame El, et al.. (2011). Argan Oil Exerts an Antiatherogenic Effect by Improving Lipids and Susceptibility of LDL to Oxidation in Type 2 Diabetes Patients. International Journal of Endocrinology. 2011. 1–8. 8 indexed citations
4.
Bennani, Houda, Jean Fiet, & A. Adlouni. (2009). Impact de l’huile d’argan sur le cancer de la prostate : étude de l’effet antiprolifératif des polyphénols. Revue Francophone des Laboratoires. 2009(416). 23–26. 8 indexed citations
5.
Cenarro, Ana, Anass Kettani, Sergio Castillo, et al.. (2007). Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family. Journal of Genetics. 86(2). 159–163. 3 indexed citations
6.
Cherki, Mounia, Hicham Berrougui, A. Drissi, A. Adlouni, & Abdelouahed Khalil. (2006). Argan oil: Which benefits on cardiovascular diseases?. Pharmacological Research. 54(1). 1–5. 59 indexed citations
7.
Bennani, Houda, A. Drissi, Frank Giton, et al.. (2006). Antiproliferative effect of polyphenols and sterols of virgin argan oil on human prostate cancer cell lines. Cancer Detection and Prevention. 31(1). 64–69. 70 indexed citations
8.
Drissi, A., et al.. (2006). Tocopherols and Saponins Derived fromArgania spinosaExert, an Antiproliferative Effect on Human Prostate Cancer. Cancer Investigation. 24(6). 588–592. 37 indexed citations
9.
Rabès, Jean‐Pierre, Mathilde Varret, A. Adlouni, et al.. (2006). Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco. Clinica Chimica Acta. 373(1-2). 62–69. 19 indexed citations
10.
Messal, Mariame El, et al.. (2006). The management of familial hypercholesterolaemia in Morocco. Acta Cardiologica. 61(5). 551–556. 2 indexed citations
11.
Messal, Mariame El, Jean‐Louis Beaudeux, A. Drissi, et al.. (2005). Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia. Clinica Chimica Acta. 366(1-2). 185–189. 26 indexed citations
12.
Derouiche, A., Mounia Cherki, A. Drissi, et al.. (2005). Nutritional Intervention Study with Argan Oil in Man: Effects on Lipids and Apolipoproteins. Annals of Nutrition and Metabolism. 49(3). 196–201. 49 indexed citations
13.
Cherki, Mounia, et al.. (2005). Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. Nutrition Metabolism and Cardiovascular Diseases. 15(5). 352–360. 64 indexed citations
14.
Cherki, Mounia, et al.. (2005). W10-P-017 Beneficial effects of enriched-argan oil diet in healthy men: Influence on HDL fluidity and paraoxonase activity. Atherosclerosis Supplements. 6(1). 51–51. 1 indexed citations
15.
Messal, Mariame El, Joan-Carles Vallvé, Josep Ribalta, et al.. (2003). Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene. Journal of Human Genetics. 48(4). 199–203. 13 indexed citations
16.
17.
Adlouni, A., et al.. (1998). Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fasting. Clinica Chimica Acta. 271(2). 179–189. 68 indexed citations
18.
Adlouni, A., Mariame El Messal, Noreddine Ghalim, & Rachid Saı̈le. (1997). Apolipoproteins and lipoprotein particles in moroccan patients with previous myocardial infarction. International Journal of Clinical & Laboratory Research. 27(2-4). 247–252. 3 indexed citations
19.
Adlouni, A., et al.. (1997). Fasting during Ramadan Induces a Marked Increase in High-Density Lipoprotein Cholesterol and Decrease in Low-Density Lipoprotein Cholesterol. Annals of Nutrition and Metabolism. 41(4). 242–249. 180 indexed citations
20.
Ghalim, Noreddine, A. Adlouni, Rachid Saı̈le, et al.. (1996). Apolipoprotein AIV of human interstitial fluid is associated with apolipoprotein AI-containing but not with AII-containing particles. International Journal of Clinical & Laboratory Research. 26(4). 224–228. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.-I. Covas Breakdown of academic impact, for papers by José Manuel Santos‐Lozano Breakdown of academic impact, for papers by Meera Penumetcha Breakdown of academic impact, for papers by Ursel Wahrburg Breakdown of academic impact, for papers by R.P. Mensink Breakdown of academic impact, for papers by Fernando Lopez‐Segura Breakdown of academic impact, for papers by Marjorie Bell Breakdown of academic impact, for papers by Christine Greene Breakdown of academic impact, for papers by JT Judd Breakdown of academic impact, for papers by Rianne Leenen
Rankless by CCL
2026